Tag: #obesity

FDA-Approved Wegovy Pill Rolls Out Nationwide, Offering Daily Alternative to Weekly Injections

Novo Nordisk says its once-daily Wegovy tablet is now widely available in the U.S., with lower self-pay prices but strict dosing rules and coverage gaps.

#wegovy, #glp1, #obesity, #cardiovascular, #fda

Pfizer Acquires Metsera in $10 Billion Deal, Re-Enters Obesity Drug Market

Pfizer acquires Metsera for $10B, marking a strategic move into the obesity drug market. The acquisition positions Pfizer against Novo Nordisk and Eli Lilly.

#pfizer, #acquisition, #pharmaceutical, #obesity, #diabetes